Brief: Transgene Receives $22.2 Million From Sale Of Part Of Its Stake In Tasly BioPharmaceuticals

Transgene SA

04/08/2020 16:51

Aug 4 (Reuters) - TRANSGENE SA  TRNG.PA :
    * TRANSGENE RECEIVES $22.2 MILLION FROM THE SALE OF PART OF
ITS
MINORITY STAKE IN TASLY BIOPHARMACEUTICALS
    * FOLLOWING THIS SHARE SALE, TRANSGENE HOLDS 17.1 MILLION
SHARES
IN TASLY BIOPHARMACEUTICALS, EQUIVALENT TO 1.58% OF CHINESE
COMPANY'S CAPITAL
    * TRANSGENE'S REMAINING SHAREHOLDING IN TASLY
BIOPHARMACEUTICALS
WOULD BE VALUED AT APPROXIMATELY $36.9 MILLION BASED ON PRICE OF
CURRENT SHARE SALE

Source text for Eikon:  ID:nBw7PdWhya 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))